Dietary Intervention to Mitigate Post-Acute COVID-19 Syndrome (NCT05977179)
A Diet Intervention Study To Mitigate Fatigue Symptoms And To Improve Muscle And Physical Function In Older Adults With Post-Acute COVID-19 Syndrome
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this study is to conduct a 16-week randomized controlled trial aimed at investigating the effectiveness of the Whole-Diet Approach when following a healthy US-style diet rich in anti-inflammatory properties. The study will focus on evaluating its impact on reducing symptoms related to Post-Acute Sequelae of SARS-CoV-2 Infection (PACS) in adults aged 50 years and older. The main research questions this study aims to answer are: 1. Does adhering to a healthy US-style diet, which is abundant in anti-inflammatory properties, effectively mitigate fatigue symptoms in adults with PACS? 2. Does adhering to a healthy US-style diet, which is abundant in anti-inflammatory properties, effectively mitigate declines in muscle function and physical performance in adults with PACS? At the beginning of the study, eligible participants will be randomly assigned to either the Dietary Intervention Group, where they will receive personalized dietary plans and weekly sessions, or the Attention Control Group, where they will attend general health sessions on a weekly basis as well. This research intends to shed light on the potential benefits of the Whole-Diet Approach and its role in ameliorating PACS-related symptoms among older adults. By comparing the outcomes of the two groups, we hope to gain valuable insights into the effectiveness of this dietary intervention in improving the quality of life for individuals dealing with PACS.
Who can join: Review the eligibility criteria below.
Location: University of Maryland, Baltimore — Baltimore, Maryland
Age range: 50 Years to 94 Years
🧪 Interventions in This Study
- Dietary intervention to mitigate Post-Acute COVID-19 Syndrome (OTHER)
- Attention Control (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Maryland, Baltimore — Baltimore, Maryland
📞 Contact the Study Coordinator
Phone: (410) 916-8191
Email: gbigman@som.umaryland.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Post-Acute COVID-19 Syndrome
- Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome — Nashville, Tennessee
- A Study of Positive Emotions With Long COVID-19 — Sacramento, California
- Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I) — Bethesda, Maryland
- Harnessing Optimism and Perseverance in the Face of Long COVID-Español — New York, New York
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research — Delafield, Wisconsin
Explore by condition: All Post-Acute COVID-19 Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.